CHINA PHARMA HOLDINGS, INC. Depreciation and Amortization
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Depreciation and Amortization of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $497.43K, a 11.01% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $356.03K, a 48.91% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for the quarter ending 2025-06-30 was $320.86K, a 56.60% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for the quarter ending 2025-03-31 was $329.31K, a 55.12% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for fiscal 2025 was $1.50M, a 42.57% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for fiscal 2024 was $2.62M, a 4.92% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for fiscal 2023 was $2.75M, a 1.97% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. depreciation, depletion and amortization for fiscal 2022 was $2.70M, a 12.54% decline from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 3 month as first filed | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 9 month as first filed | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $497.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $853.46K derived: sum of 2 quarters · filed 2026-04-01 | $1.17M derived: sum of 3 quarters · filed 2026-04-01 | $1.50M 10-K · filed 2026-04-01 | ||
| 2025-09-30 | $356.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $676.90K derived: sum of 2 quarters · filed 2025-11-12 | $1.01M 10-Q · filed 2025-11-12 | $1.45M derived: sum of 4 quarters · filed 2026-04-01 | ||
| 2025-06-30 | $320.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $650.18K 10-Q · filed 2025-08-14 | $1.10M derived: sum of 3 quarters · filed 2026-04-01 | $1.80M derived: sum of 4 quarters · filed 2026-04-01 | ||
| 2025-03-31 | $329.31K 10-Q · filed 2025-05-14 | $777.39K derived: sum of 2 quarters · filed 2026-04-01 | $1.47M derived: sum of 3 quarters · filed 2026-04-01 | $2.21M derived: sum of 4 quarters · filed 2026-04-01 | ||
| 2024-12-31 | $448.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.15M derived: sum of 2 quarters · filed 2026-04-01 | $1.88M derived: sum of 3 quarters · filed 2026-04-01 | $2.62M 10-K · filed 2026-04-01 | ||
| 2024-09-30 | $696.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.44M derived: sum of 2 quarters · filed 2025-11-12 | $2.17M 10-Q · filed 2025-11-12 | $2.87M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $739.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.47M 10-Q · filed 2025-08-14 | $2.17M derived: sum of 3 quarters · filed 2025-08-14 | $2.85M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $733.80K 10-Q · filed 2025-05-14 | $1.43M derived: sum of 2 quarters · filed 2025-05-14 | $2.11M derived: sum of 3 quarters · filed 2025-05-14 | $2.81M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $695.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.38M derived: sum of 2 quarters · filed 2025-03-31 | $2.07M derived: sum of 3 quarters · filed 2025-03-31 | $2.75M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $683.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.38M derived: sum of 2 quarters · filed 2024-11-13 | $2.06M 10-Q · filed 2024-11-13 | $2.70M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $694.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.37M 10-Q · filed 2024-08-14 | $2.01M derived: sum of 3 quarters · filed 2024-08-14 | $2.68M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $679.88K 10-Q · filed 2023-05-12 | $1.32M derived: sum of 2 quarters · filed 2024-04-01 | $1.98M derived: sum of 3 quarters · filed 2024-04-01 | $2.67M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-12-31 | $639.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.30M derived: sum of 2 quarters · filed 2024-04-01 | $1.99M derived: sum of 3 quarters · filed 2024-04-01 | $2.70M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $664.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.35M derived: sum of 2 quarters · filed 2023-11-13 | $2.06M 10-Q · filed 2023-11-13 | $2.77M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $683.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.40M 10-Q · filed 2023-08-14 | $2.11M derived: sum of 3 quarters · filed 2023-08-14 | $3.08M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $713.56K 10-Q · filed 2023-05-12 | $1.42M derived: sum of 2 quarters · filed 2023-05-12 | $2.40M derived: sum of 3 quarters · filed 2023-05-12 | $3.10M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $710.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.69M derived: sum of 2 quarters · filed 2023-03-30 | $2.39M derived: sum of 3 quarters · filed 2023-03-30 | $3.09M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $976.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.68M derived: sum of 2 quarters · filed 2022-11-14 | $2.38M 10-Q · filed 2022-11-14 | $3.08M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $700.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.40M 10-Q · filed 2022-08-11 | $2.10M derived: sum of 3 quarters · filed 2022-08-11 | $2.78M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $700.19K 10-Q · filed 2022-05-12 | $1.40M derived: sum of 2 quarters · filed 2022-05-12 | $2.07M derived: sum of 3 quarters · filed 2022-05-12 | $2.72M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $701.11K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.37M derived: sum of 2 quarters · filed 2022-03-30 | $2.02M derived: sum of 3 quarters · filed 2022-03-30 | $2.68M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $673.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.32M derived: sum of 2 quarters · filed 2021-11-12 | $1.98M 10-Q · filed 2021-11-12 | $2.65M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $649.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.31M 10-Q · filed 2021-08-13 | $1.97M derived: sum of 3 quarters · filed 2021-08-13 | $2.66M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $655.92K 10-Q · filed 2021-05-14 | $1.32M derived: sum of 2 quarters · filed 2021-05-14 | $2.01M derived: sum of 3 quarters · filed 2021-05-14 | $2.79M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $1.35M derived: sum of 2 quarters · filed 2021-03-26 | $2.13M derived: sum of 3 quarters · filed 2021-03-26 | $2.93M 10-K · filed 2021-03-26 | ||
| 2019-09-30 | $685.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.47M derived: sum of 2 quarters · filed 2020-11-13 | $2.26M 10-Q · filed 2020-11-13 | $3.02M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $780.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.58M 10-Q · filed 2020-08-13 | $2.34M derived: sum of 3 quarters · filed 2020-08-13 | $3.12M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $795.48K 10-Q · filed 2020-05-14 | $1.56M derived: sum of 2 quarters · filed 2020-05-14 | $2.34M derived: sum of 3 quarters · filed 2020-05-14 | $3.19M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $759.63K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.54M derived: sum of 2 quarters · filed 2020-03-30 | $2.40M derived: sum of 3 quarters · filed 2020-03-30 | $3.26M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $784.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.64M derived: sum of 2 quarters · filed 2019-11-14 | $2.50M 10-Q · filed 2019-11-14 | $3.34M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $852.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.71M 10-Q · filed 2019-08-14 | $2.56M derived: sum of 3 quarters · filed 2019-08-14 | $3.38M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $861.43K 10-Q · filed 2019-05-14 | $1.70M derived: sum of 2 quarters · filed 2019-05-14 | $2.52M derived: sum of 3 quarters · filed 2019-05-14 | $3.34M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $843.46K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $1.66M derived: sum of 2 quarters · filed 2019-03-28 | $2.48M derived: sum of 3 quarters · filed 2019-03-28 | $3.29M 10-K · filed 2019-03-28 | ||
| 2017-09-30 | $819.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.63M derived: sum of 2 quarters · filed 2018-11-14 | $2.45M 10-Q · filed 2018-11-14 | $2.94M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $812.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.63M 10-Q · filed 2018-08-14 | $2.12M derived: sum of 3 quarters · filed 2018-08-14 | $2.98M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $815.39K 10-Q · filed 2018-05-14 | $1.31M derived: sum of 2 quarters · filed 2018-05-14 | $2.17M derived: sum of 3 quarters · filed 2018-05-14 | $3.04M derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $495.01K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.35M derived: sum of 2 quarters · filed 2018-04-02 | $2.22M derived: sum of 3 quarters · filed 2018-04-02 | $3.08M 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $854.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.73M derived: sum of 2 quarters · filed 2017-11-14 | $2.58M 10-Q · filed 2017-11-14 | $3.41M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $871.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.73M 10-Q · filed 2017-08-14 | $2.56M derived: sum of 3 quarters · filed 2017-08-14 | $3.44M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $857.20K 10-Q · filed 2017-05-11 | $1.69M derived: sum of 2 quarters · filed 2017-05-11 | $2.57M derived: sum of 3 quarters · filed 2017-05-11 | $3.50M derived: sum of 4 quarters · filed 2017-05-11 | ||
| 2015-12-31 | $828.77K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $1.71M derived: sum of 2 quarters · filed 2017-03-31 | $2.65M derived: sum of 3 quarters · filed 2017-03-31 | $3.60M 10-K · filed 2017-03-31 | ||
| 2015-09-30 | $885.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.82M derived: sum of 2 quarters · filed 2016-11-14 | $2.77M 10-Q · filed 2016-11-14 | $3.54M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $933.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.88M 10-Q · filed 2016-08-11 | $2.66M derived: sum of 3 quarters · filed 2016-08-11 | $3.07M derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $951.21K 10-Q · filed 2016-05-16 | $1.72M derived: sum of 2 quarters · filed 2016-05-16 | $2.14M derived: sum of 3 quarters · filed 2016-05-16 | $2.44M derived: sum of 4 quarters · filed 2016-05-16 | ||
| 2014-12-31 | $771.61K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.19M derived: sum of 2 quarters · filed 2016-03-30 | $1.49M derived: sum of 3 quarters · filed 2016-03-30 | $1.79M 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $417.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | $715.27K derived: sum of 2 quarters · filed 2015-12-28 | $1.01M 10-Q · filed 2015-12-28 | $1.59M derived: sum of 4 quarters · filed 2015-12-28 | ||
| 2014-06-30 | $297.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $596.82K 10-Q · filed 2015-12-28 | $1.17M derived: sum of 3 quarters · filed 2015-12-28 | $1.51M derived: sum of 4 quarters · filed 2015-12-28 | ||
| 2014-03-31 | $298.95K 10-Q · filed 2015-12-28 | $34.01K 10-Q · filed 2014-05-15 | $872.07K derived: sum of 2 quarters · filed 2015-12-28 | $1.21M derived: sum of 3 quarters · filed 2015-12-28 | $1.88M derived: sum of 4 quarters · filed 2015-12-28 | |
| 2013-12-31 | $573.11K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $915.28K derived: sum of 2 quarters · filed 2015-12-28 | $1.58M derived: sum of 3 quarters · filed 2015-12-28 | $1.61M 10-K · filed 2015-12-28 | ||
| 2013-09-30 | $342.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $1.00M derived: sum of 2 quarters · filed 2014-11-14 | $1.04M 10-Q · filed 2014-11-14 | $1.41M derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2013-06-30 | $661.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $697.55K 10-Q · filed 2014-08-14 | $1.06M derived: sum of 3 quarters · filed 2014-08-14 | $1.43M derived: sum of 4 quarters · filed 2014-08-14 | ||
| 2013-03-31 | $36.09K 10-Q · filed 2014-05-15 | $402.22K derived: sum of 2 quarters · filed 2014-05-15 | $769.70K derived: sum of 3 quarters · filed 2014-05-15 | $1.13M derived: sum of 4 quarters · filed 2014-05-15 | ||
| 2012-12-31 | $366.13K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $733.60K derived: sum of 2 quarters · filed 2014-03-20 | $1.10M derived: sum of 3 quarters · filed 2014-03-20 | $1.46M 10-K · filed 2014-03-20 | ||
| 2012-09-30 | $367.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $731.42K derived: sum of 2 quarters · filed 2013-11-14 | $1.10M 10-Q · filed 2013-11-14 | $1.19M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-06-30 | $363.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $729.17K 10-Q · filed 2013-08-14 | $822.10K derived: sum of 3 quarters · filed 2013-08-14 | $1.01M derived: sum of 4 quarters · filed 2013-08-14 | ||
| 2012-03-31 | $365.22K 10-Q · filed 2012-05-14 | $458.15K derived: sum of 2 quarters · filed 2012-05-14 | $649.15K derived: sum of 3 quarters · filed 2012-05-14 | $1.10M derived: sum of 4 quarters · filed 2012-05-14 | ||
| 2011-12-31 | $92.93K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $283.93K derived: sum of 2 quarters · filed 2012-03-14 | $732.83K derived: sum of 3 quarters · filed 2012-03-14 | $1.17M 10-K · filed 2012-03-14 | ||
| 2011-09-30 | $191.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $639.90K derived: sum of 2 quarters · filed 2012-03-06 | $1.08M 10-Q/A · filed 2012-03-06 | $3.15M 10-Q · filed 2011-11-10 | $1.32M derived: sum of 4 quarters · filed 2012-05-14 | |
| 2011-06-30 | $448.90K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-09-06 | $890.89K 10-Q/A · filed 2011-09-06 | $1.12M derived: sum of 3 quarters · filed 2012-05-14 | $1.55M derived: sum of 4 quarters · filed 2012-05-14 | ||
| 2011-03-31 | $441.99K 10-Q · filed 2012-05-14 | $675.94K derived: sum of 2 quarters · filed 2012-05-14 | $1.11M derived: sum of 3 quarters · filed 2012-05-14 | |||
| 2010-12-31 | $233.94K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $663.43K derived: sum of 2 quarters · filed 2012-03-14 | $1.51M 10-K · filed 2012-03-14 | |||
| 2010-09-30 | $429.49K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $1.27M 10-Q/A · filed 2012-03-06 | ||||
| 2010-06-30 | $841.76K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |